Sign In
Buy QTRX
$3.22
-0.270 (-7.74%)
At Close: Jun 23, 2026
Quanterix Announces Landmark Nature Study Redefining Alzheimer's Disease Neuropathology Prevalence
07:30am, Monday, 22'nd Dec 2025
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced public
Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth
04:15pm, Thursday, 20'th Nov 2025
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced the pu
Quanterix Corporation (NASDAQ:QTRX) Receives Consensus Rating of “Hold” from Analysts
03:33am, Monday, 17'th Nov 2025
Quanterix Corporation (NASDAQ: QTRX - Get Free Report) has earned a consensus rating of "Hold" from the five analysts that are currently covering the firm, MarketBeat reports. One analyst has rated th
Quanterix Corporation (QTRX) Q3 2025 Earnings Call Transcript
07:11pm, Monday, 10'th Nov 2025
Quanterix Corporation ( QTRX ) Q3 2025 Earnings Call November 10, 2025 4:30 PM EST Company Participants Joshua Young Masoud Toloue - President, CEO & Director Vandana Sriram - CFO & Treasurer Conferen
Quanterix Corporation (QTRX) Reports Q3 Loss, Tops Revenue Estimates
06:13pm, Monday, 10'th Nov 2025
Quanterix Corporation (QTRX) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to a loss of $0.22 per share a year ago.
Quanterix Releases Financial Results for the Third Quarter of 2025
04:01pm, Monday, 10'th Nov 2025
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced financ
Quanterix To Report Third Quarter 2025 Financial Results on November 10, 2025
07:00am, Monday, 03'rd Nov 2025
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conferen
Critical Review: Generation Alpha (OTCMKTS:GNAL) versus Quanterix (NASDAQ:QTRX)
01:37am, Sunday, 26'th Oct 2025
Generation Alpha (OTCMKTS:GNAL - Get Free Report) and Quanterix (NASDAQ: QTRX - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on
Quanterix Corporation (NASDAQ:QTRX) Given Average Rating of “Hold” by Brokerages
01:58am, Thursday, 23'rd Oct 2025
Quanterix Corporation (NASDAQ: QTRX - Get Free Report) has been given an average rating of "Hold" by the six research firms that are presently covering the company, Marketbeat Ratings reports. One equ
All You Need to Know About Quanterix (QTRX) Rating Upgrade to Buy
01:01pm, Thursday, 02'nd Oct 2025
Quanterix (QTRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit
04:30pm, Thursday, 21'st Aug 2025
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced the New York State Departmen
Down 24.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Quanterix (QTRX)
10:35am, Tuesday, 12'th Aug 2025
Quanterix (QTRX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising
Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference
07:00am, Monday, 11'th Aug 2025
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that its executive leadershi
Quanterix Corporation (QTRX) Q2 2025 Earnings Call Transcript
02:27am, Saturday, 09'th Aug 2025
Quanterix Corporation (NASDAQ:QTRX ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 AM ET Company Participants Joshua Young - Corporate Participant Masoud Toloue - President, CEO & Director Vand
